These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 23743486)

  • 21. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
    Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
    N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
    Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH
    JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV; Tsao L
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of intravenous vasodilators in acute heart failure management.
    Piper S; McDonagh T
    Eur J Heart Fail; 2014 Aug; 16(8):827-34. PubMed ID: 25100108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study.
    Chow SL; O'Barr SA; Peng J; Chew E; Pak F; Quist R; Patel P; Patterson JH; Heywood JT
    Circ Heart Fail; 2011 Jul; 4(4):450-5. PubMed ID: 21576282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of NT-proBNP, proANP and novel biomarkers: copeptin and proadrenomedullin with LVEF and NYHA in patients with ischemic CHF, non-ischemic CHF and arterial hypertension.
    Vondráková D; Málek F; Ošťádal P; Vránová J; Miroslav P; Schejbalová M; Neužil P
    Int J Cardiol; 2011 Aug; 150(3):343-4. PubMed ID: 21640398
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital policies for treatment of acute decompensated heart failure.
    Vats V; DiDomenico RJ; Wojtynek JE; Theobald JC; Schumock GT
    Ann Pharmacother; 2007 Apr; 41(4):562-7. PubMed ID: 17374618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute decompensated heart failure.
    Brown JR; Gottlieb SS
    Cardiol Clin; 2012 Nov; 30(4):665-71. PubMed ID: 23102040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
    Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
    JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospitalized patients with acute decompensated heart failure: recognition, risk stratification, and treatment review.
    Amin A
    J Hosp Med; 2008 Nov; 3(6 Suppl):S16-24. PubMed ID: 19084891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD; Parissis JT; Filippatos G
    Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Natriuretic peptides in the therapy of acute decompensated heart failure].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1738-43. PubMed ID: 21877307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute decompensated heart failure: pathophysiology and treatment.
    Onwuanyi A; Taylor M
    Am J Cardiol; 2007 Mar; 99(6B):25D-30D. PubMed ID: 17378992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department.
    Peacock WF
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S41-8. PubMed ID: 12439430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea.
    Wu AH; Tabas J; Stein J; Potocki M; Mueller C; McCord J; Richards M; Hartmann O; Nowak R; Peacock WF; Ponikowski P; Moeckel M; Hogan C; Filippatos GS; Di Somma S; Anand I; Ng L; Neath SX; Christenson R; Morgenthaler NG; Anker SD; Maisel AS
    Biomarkers; 2012 Sep; 17(6):490-7. PubMed ID: 22616939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
    Rifkin W
    JAMA; 2002 Aug; 288(5):572; author reply 572-3. PubMed ID: 12150662
    [No Abstract]   [Full Text] [Related]  

  • 40. Nesiritide in acute heart failure.
    de Moraes Barros GD; de Carvalho Leite CR
    Lancet; 2003 Sep; 362(9388):999. PubMed ID: 14511941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.